Advanced Stem Cell Research Available for All

Since its discovery of the cord lining’s miraculous source of stem cells in 2004, CellResearch Corporation has been committed to availing the benefits of this breakthrough to everyone. Though the company’s strength is in the field of skin and wound care, its technology can be applied to almost any other medical field. There have been unlimited opportunities for CellResearchCorp to extend its pioneering stem cell expertise to research partners and medical affiliates around the word.


Cord Lining Stem cell technology can be applied to almost any medical field
 
 

 Free Stem Cell Expertise for Patients
with Hard-to-heal Wounds

The CREATE A BETTER WORLD: Stem Cell Research Initiative was launched in the early 2000s with the treatment of patients with chronic burns and wounds. Many of these cases had achieved success where conventional treatments had failed. During treatment of burns, chronic wounds and ulcers, cord lining stem cells were placed on scaffolds, and then applied onto the wounds. This has been proven to enhance recovery of chronic wounds without requiring a skin graft. Thousands of patients have benefited from these cord lining stem cell therapies in South East Asia. Stem cell expertise as well as stem cell medication had been given free of charge by the CREATE A BETTER WORLD Initiative to the institutions that offered these treatments.

You are able to read about some of these success cases on burns and on chronic wounds and ulcers. (Warning: there are photographs of extreme trauma and wounds on these pages that some may find disturbing)

CREATE A BETTER WORLD will continue to provide access to its cord lining stem cell technology, as well as provide treatments and support for clinics and doctors around the world caring for those who are most in need. To request for support from the Initiative, please contact CellResearchCorp.


Many cases of patients with chronic burns and wounds had achieved success with cord lining stem cell therapy where conventional treatments had failed
 
 

 Furthering the Future of Stem Cell Therapy

The work of CREATE A BETTER WORLD does not end with wound therapy. It also hopes to enable researchers to discover new therapies for a whole host of other diseases. To that end, CellResearch Laboratories provides free access to cord lining stem cells to research institutions around the world, enabling them to further their work on complicated diseases such as diabetes, Haemophilia A, Parkinson’s and heart diseases.

The work of institutions such as the AO Research Institute in Davos on bone and cartilage can be found here, Singapore National Eye Centre on corneal resurfacing can be found here, National Cancer Centre Singapore on diabetes can be found here, and the University Heart Centre in Hamburg on cell-based heart therapy can be found here.

All of these research initiatives were made possible through the contribution of cord lining stem cells from CellResearchCorp. Other research partnerships using Cord Lining Stem Cells on Haemophilia A, neurological disorders, and Parkinson’s can also be found on the website.


CREATE A BETTER WORLD does not stop with wound therapy. It also hopes to enable researchers to discover new therapies for a whole host of other diseases.
 
 

 The Future of Wound Healing, Powered By Cord Lining Stem Cells

Recognising the immense potential of Cord Lining Stem Cells for the treatment of chronic wounds, burns and ulcers, CREATE A BETTER WORLD is embarking on a mission to make stem cell treatment readily available to those in need around the world.

To that end, a part of the proceeds from the company’s businesses, which includes cord tissue banking licensing (in the form of GlobalCord) and skincare (CALECIM® Professional) will go towards the development of a therapeutic drug called CorliCyte™. CorliCyte™’s first indication is targeted towards the healing of chronic diabetic wounds and CellResearchCorp is confident that it will be able to make this product available to the hundreds of millions suffering from chronic diabetic wounds, burns, ulcers and other complicated wounds around 2020. CorliCyte™ is currently progressing smoothly towards its first phase of USFDA trials.

If you are interested in the work of CREATE A BETTER WORLD and would like to get involved, please contact us.


CREATE A BETTER WORLD is embarking on a mission to make stem cell treatment readily available to those in need around the world.